Company: ADZCF
Filing Date: 2025-10-31
Form Type: 424B2
Source: 0000950103-25-014057
Chunk: 19

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-10-31
Form: 424B2
Chunk 19
---
 sell the Securities to you in addition to any           
 compensation they would receive for the sale of the Securities.                                                                                 |

<div align='center'>PS-11</div>

| · | We, UBS or Our or                                                                                                                             
 Its Affiliates May Publish Research, Express Opinions or Provide Recommendations That are Inconsistent with Investing in or Holding the       
 Securities. Any Such Research, Opinions or Recommendations Could Adversely Affect the Value of the Underlying and the Value of the Securities 
 — We, UBS or our or its affiliates may publish research from time to time on financial markets and other matters that could adversely         
 affect the value of the Underlying and the value of the Securities, or express opinions or provide recommendations that are inconsistent      
 with purchasing or holding the Securities. Any research, opinions or recommendations expressed by us, UBS or our or its affiliates may        
 not be consistent with each other and may be modified from time to time without notice. You should make your own independent investigation    
 of the merits of investing in the Securities and the Underlying.                                                                              |

| · | Potential Conflicts                                                                                                                               
 of Interest — Deutsche Bank AG or its affiliates may engage in business with the issuers of the securities included in the Underlying,            
 which may present a conflict between Deutsche Bank AG and you, as a holder of the Securities. We and our affiliates play a variety of             
 roles in connection with the issuance of the Securities, including acting as calculation agent, hedging our obligations under the Securities      
 and determining the Issuer’s estimated value of the Securities on the Trade Date and the price, if any, at which we or our affiliates             
 would be willing to purchase the Securities from you in secondary market transactions. In performing these roles, our economic interests          
 and those of our affiliates are potentially adverse to your interests as an investor in the Securities. The calculation agent will determine,     
 among other things, all values, prices and levels required to be determined for the purposes of the Securities on any relevant date or            
 time. The calculation agent will also be responsible for determining whether a market disruption event has occurred and make other determinations 
 with respect to the Underlying under the circumstances described in the product supplement. In making these determinations, the calculation       
 agent may be required to make discretionary judgments. In making these discretionary judgments, the fact that we are the calculation agent        
 may cause us to have economic interests that are adverse to your interests as an investor in the Securities, and our determinations as            
 calculation agent may adversely affect